Willow Biosciences Q1 FY23 Revenue Grows To $203K, Still In Development Stage And On 'A Solid Trajectory'
Willow Biosciences Inc. (OTCQB: CANSF) (TSX:WLLW) released its financial and operating results for the three months ended March 31, 2023, revealing revenue of CA$274,000 ($203,000) compared to no revenue in Q1 2022.
